PATHOPHYSIOLOGICAL CONCENTRATIONS OF GLUCOSE PROMOTE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY A SUPEROXIDE-DEPENDENT PATHWAY

被引:206
作者
KAWAMURA, M
HEINECKE, JW
CHAIT, A
机构
[1] UNIV WASHINGTON, DEPT MED, DIV METAB ENDOCRINOL & NUTR RG26, SEATTLE, WA 98195 USA
[2] WASHINGTON UNIV, DEPT MED, ST LOUIS, MO 63110 USA
关键词
PEROXIDATION; SUPEROXIDE; HYDROGEN PEROXIDE; MACROPHAGES; DIABETES;
D O I
10.1172/JCI117396
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Oxidized lipoproteins may be important in the pathogenesis of atherosclerosis. Because diabetic subjects are particularly prone to vascular disease, and glucose autoxidation and protein glycation generate reactive oxygen species, we explored the role of glucose in lipoprotein oxidation. Glucose enhanced low density lipoprotein (LDL) oxidation at concentrations seen in the diabetic state. Conjugated dienes, thiobarbituric acid reactive substances, electrophoretic mobility, and degradation by macrophages were increased when LDL was modified in the presence of glucose. In contrast, free lysine groups and fibroblast degradation were reduced. Although loss of reactive lysine groups could be due to either oxidative modification or nonenzymatic glycation of apolipoprotein B-100, inhibition of lipid peroxidation by the metal chelator, diethylenetriamine pentaacetic acid, blocked the changes in free lysines. Thus, glycation of lysine residues is unlikely to account for the alterations in macrophage and fibroblast uptake of LDL modified in the presence of glucose. Glucose-mediated enhancement of LDL oxidation was partially blocked by superoxide dismutase and nearly completely inhibited by butylated hydroxytoluene. These findings indicate that glucose enhances LDL lipid peroxidation by an oxidative pathway involving superoxide and raise the possibility that the chronic hyperglycemia of diabetes accelerates lipoprotein oxidation, thereby promoting diabetic vascular disease.
引用
收藏
页码:771 / 778
页数:8
相关论文
共 50 条
[21]  
HAMILTON TA, 1990, J IMMUNOL, V144, P2343
[22]  
HEINECKE JW, 1987, J BIOL CHEM, V262, P10098
[23]   IRON AND COPPER PROMOTE MODIFICATION OF LOW-DENSITY LIPOPROTEIN BY HUMAN ARTERIAL SMOOTH-MUSCLE CELLS IN CULTURE [J].
HEINECKE, JW ;
ROSEN, H ;
CHAIT, A .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (05) :1890-1894
[24]   SUPEROXIDE-MEDIATED MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY ARTERIAL SMOOTH-MUSCLE CELLS [J].
HEINECKE, JW ;
BAKER, L ;
ROSEN, H ;
CHAIT, A .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (03) :757-761
[25]   SUPEROXIDE INITIATES OXIDATION OF LOW-DENSITY-LIPOPROTEIN BY HUMAN-MONOCYTES [J].
HIRAMATSU, K ;
ROSEN, H ;
HEINECKE, JW ;
WOLFBAUER, G ;
CHAIT, A .
ARTERIOSCLEROSIS, 1987, 7 (01) :55-60
[26]   AUTOXIDATIVE GLYCOSYLATION AND POSSIBLE INVOLVEMENT OF PEROXIDES AND FREE-RADICALS IN LDL MODIFICATION BY GLUCOSE [J].
HUNT, JV ;
SMITH, CCT ;
WOLFF, SP .
DIABETES, 1990, 39 (11) :1420-1424
[27]   HYDROXYL RADICAL PRODUCTION AND AUTOXIDATIVE GLYCOSYLATION - GLUCOSE AUTOXIDATION AS THE CAUSE OF PROTEIN DAMAGE IN THE EXPERIMENTAL GLYCATION MODEL OF DIABETES-MELLITUS AND AGING [J].
HUNT, JV ;
DEAN, RT ;
WOLFF, SP .
BIOCHEMICAL JOURNAL, 1988, 256 (01) :205-212
[28]   DOES SUPEROXIDE RADICAL HAVE A ROLE IN MACROPHAGE-MEDIATED OXIDATIVE MODIFICATION OF LDL [J].
JESSUP, W ;
SIMPSON, JA ;
DEAN, RT .
ATHEROSCLEROSIS, 1993, 99 (01) :107-120
[29]   DIABETES AND CARDIOVASCULAR RISK-FACTORS - FRAMINGHAM STUDY [J].
KANNEL, WB ;
MCGEE, DL .
CIRCULATION, 1979, 59 (01) :8-13
[30]   TOXICITY OF OXIDIZED LOW-DENSITY-LIPOPROTEIN TO CULTURED FIBROBLASTS IS SELECTIVE FOR S-PHASE OF THE CELL-CYCLE [J].
KOSUGI, K ;
MOREL, DW ;
DICORLETO, PE ;
CHISOLM, GM .
JOURNAL OF CELLULAR PHYSIOLOGY, 1987, 130 (03) :311-320